BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36685502)

  • 1. Comprehensive comparative analysis of prognostic value of serum systemic inflammation biomarkers for colorectal cancer: Results from a large multicenter collaboration.
    Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Song M; Zhang X; Liu X; Lin S; Yang M; Hu C; Tang M; Deng L; Hu W; Shi H
    Front Immunol; 2022; 13():1092498. PubMed ID: 36685502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
    Xie H; Ruan G; Wei L; Deng L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Yang M; Song C; Zhang X; Shi H
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):869-878. PubMed ID: 36852672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory burden as a prognostic biomarker for cancer.
    Xie H; Ruan G; Ge Y; Zhang Q; Zhang H; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Shi H
    Clin Nutr; 2022 Jun; 41(6):1236-1243. PubMed ID: 35504166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Neutrophil-to-Lymphocyte Ratio (NLR) Is a Preoperative Inflammation Biomarker of Poor Prognosis in HIV-Infected Patients with Colorectal Cancer: A Retrospective Study.
    Deng L; Si Y; Wu Q; Cao Y; Lian S; Li L
    Can J Gastroenterol Hepatol; 2023; 2023():7966625. PubMed ID: 36923659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the assessment of malnutrition in cancer: Using systemic inflammation markers as a supplement to the inflammation items of the GLIM criteria.
    Xie H; Yuan K; Ruan G; Wei L; Zhang H; Ge Y; Lin S; Song M; Wang Z; Liu C; Shi J; Liu X; Yang M; Zheng X; Chen Y; Zhang X; Shi H
    Clin Nutr; 2023 Oct; 42(10):2036-2044. PubMed ID: 37672850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I-III colorectal cancer.
    Xie H; Wei L; Liu M; Liang Y; Yuan G; Gao S; Wang Q; Lin X; Tang S; Gan J
    BMC Cancer; 2022 Dec; 22(1):1316. PubMed ID: 36522702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cancer inflammation prognostic index is a valuable biomarker for predicting the survival of patients with stage I-III colorectal cancer.
    Xie H; Wei L; Liu M; Liang Y; Wang Q; Tang S; Gan J
    Sci Rep; 2023 Oct; 13(1):18080. PubMed ID: 37872322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-albumin ratio as a biomarker for postoperative complications and long-term prognosis in patients with colorectal cancer undergoing surgical treatment.
    Xie H; Wei L; Liu M; Liang Y; Yuan G; Gao S; Wang Q; Lin X; Tang S; Gan J
    Front Nutr; 2022; 9():976216. PubMed ID: 36458178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
    Hao JP; Ma A
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment Albumin-to-Fibrinogen Ratio is a Promising Biomarker for Predicting Postoperative Clinical Outcomes in Patients with Colorectal Cancer.
    Xie H; Yuan G; Liu M; Huang S; Wei L; Tang S; Gan J
    Nutr Cancer; 2022; 74(8):2896-2909. PubMed ID: 35193433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
    Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
    Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of nutritional risk and systemic inflammation with survival in patients with colorectal cancer who underwent curative surgery.
    Nakamura Y; Imada A; Fukugaki A; Kanto S; Yamaura T; Kinjo Y; Kuroda N
    Clin Nutr ESPEN; 2022 Jun; 49():417-424. PubMed ID: 35623847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study.
    Liu B; Zhao Y; Guo L
    Medicine (Baltimore); 2018 Oct; 97(40):e11780. PubMed ID: 30290589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nomograms integrating preoperative serum lipid derivative and systemic inflammatory marker of patients with non-metastatic colorectal cancer undergoing curative resection.
    Huang D; Zheng S; Huang F; Chen J; Zhang Y; Chen Y; Li B
    Front Oncol; 2023; 13():1100820. PubMed ID: 36969019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Immune-Inflammation Index Predicts Tumor Recurrence after Radical Resection for Colorectal Cancer.
    Nakamoto S; Ohtani Y; Sakamoto I; Hosoda A; Ihara A; Naitoh T
    Tohoku J Exp Med; 2023 Nov; 261(3):229-238. PubMed ID: 37673651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of serum bilirubin in stage IV colorectal cancer patients.
    Yang L; Ge LY; Yu T; Liang Y; Yin Y; Chen H
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 29168585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer.
    Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC
    Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer.
    Zhou S; He Q; Sheng N; Gong J; Ren J; Wang Z
    World J Surg Oncol; 2022 Jan; 20(1):18. PubMed ID: 35033097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.